
Integer Holdings Corporation (NYSE:ITGR – Free Report) – Equities researchers at Zacks Research cut their Q2 2026 earnings per share (EPS) estimates for shares of Integer in a report issued on Thursday, May 21st. Zacks Research analyst Team now expects that the medical equipment provider will earn $1.41 per share for the quarter, down from their prior forecast of $1.57. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for Integer’s current full-year earnings is $6.04 per share. Zacks Research also issued estimates for Integer’s Q4 2026 earnings at $1.77 EPS, Q3 2027 earnings at $1.87 EPS and FY2027 earnings at $6.87 EPS.
Several other equities analysts have also commented on ITGR. Weiss Ratings upgraded shares of Integer from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, February 24th. Truist Financial upped their target price on shares of Integer from $95.00 to $97.00 and gave the stock a “buy” rating in a research report on Friday, February 20th. Raymond James Financial restated an “outperform” rating and issued a $101.00 price target on shares of Integer in a research note on Monday, February 23rd. Wells Fargo & Company boosted their price objective on Integer from $72.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, February 20th. Finally, Piper Sandler reissued an “overweight” rating and issued a $97.00 price objective (up from $87.00) on shares of Integer in a report on Friday, May 1st. Four equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $98.29.
Integer Stock Performance
Shares of NYSE ITGR opened at $90.26 on Wednesday. The company has a quick ratio of 2.38, a current ratio of 3.75 and a debt-to-equity ratio of 0.77. The firm’s 50-day moving average price is $87.04 and its two-hundred day moving average price is $82.16. Integer has a 52-week low of $62.00 and a 52-week high of $123.78. The stock has a market capitalization of $3.07 billion, a P/E ratio of 22.51, a P/E/G ratio of 2.13 and a beta of 0.67.
Integer (NYSE:ITGR – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing the consensus estimate of $1.21 by ($0.01). The firm had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. Integer had a net margin of 7.64% and a return on equity of 12.83%. The firm’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.31 earnings per share. Integer has set its FY 2026 guidance at 5.830-6.400 EPS.
Institutional Investors Weigh In On Integer
A number of institutional investors have recently modified their holdings of ITGR. Tudor Investment Corp ET AL increased its position in Integer by 50,787.5% in the 3rd quarter. Tudor Investment Corp ET AL now owns 29,500,000 shares of the medical equipment provider’s stock worth $28,606,000 after purchasing an additional 29,442,029 shares during the last quarter. Irenic Capital Management LP acquired a new position in Integer in the fourth quarter worth approximately $99,109,000. Alliancebernstein L.P. lifted its stake in Integer by 885.1% in the second quarter. Alliancebernstein L.P. now owns 1,106,091 shares of the medical equipment provider’s stock valued at $136,016,000 after acquiring an additional 993,810 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in Integer by 1,141.6% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 819,046 shares of the medical equipment provider’s stock worth $72,076,000 after acquiring an additional 753,081 shares in the last quarter. Finally, Millennium Management LLC increased its stake in shares of Integer by 3,350.2% during the 4th quarter. Millennium Management LLC now owns 677,108 shares of the medical equipment provider’s stock worth $53,106,000 after purchasing an additional 657,483 shares during the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.
Insider Activity at Integer
In related news, VP Tommy P. Thomas sold 825 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The shares were sold at an average price of $85.00, for a total value of $70,125.00. Following the completion of the transaction, the vice president owned 4,381 shares of the company’s stock, valued at approximately $372,385. This trade represents a 15.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.10% of the stock is currently owned by insiders.
Integer Company Profile
Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.
Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.
Further Reading
- Five stocks we like better than Integer
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.
